Management of cancer pain
- 1 May 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 353 (9165), 1695-1700
- https://doi.org/10.1016/s0140-6736(99)01310-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration studyPain, 1999
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997
- Transdermal fentanyl versussustained-release oral morphine in cancer pain: Preference, efficacy, and quality of lifeJournal of Pain and Symptom Management, 1997
- Symptom prevalence, characteristics and distress in a cancer populationQuality of Life Research, 1994
- Quality of life: Concepts and definitionJournal of Pain and Symptom Management, 1994
- Drugs in the treatment of painCurrent Opinion In Anesthesiology, 1993
- Cancer pain: pathophysiology and syndromesThe Lancet, 1992
- The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusionsPain, 1990
- Original article: Quality-of-life assessment during a palliative care programmeAnnals of Oncology, 1990
- The Nature of Suffering and the Goals of MedicineNew England Journal of Medicine, 1982